<DOC>
	<DOC>NCT01254318</DOC>
	<brief_summary>This will be a retrospective study that includes retrospective chart reviews at major institutions across Canada. The intent of the study is to generate both regional and national incidence data for non-Candida invasive fungal infections (IFI) in high risk participants. The study will include participants receiving stem cell transplant and high dose chemotherapy treatment for leukemia.</brief_summary>
	<brief_title>Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>To be eligible for study inclusion, the participant must have: A hematological malignancy requiring high dose chemotherapy with or without bone marrow transplant The participant is not eligible for study inclusion if: Their IFI is not related to hematological malignancies.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>hematological malignancy</keyword>
	<keyword>fungal infection</keyword>
	<keyword>leukemia</keyword>
</DOC>